Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-03-08 | 2019-04-17 | 78081 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-03-05 | 2020-07-20 | 77655 |
| PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-03-04 | 2020-05-19 | 77465 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-03-04 | 2019-09-12 | 77462 |
| IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-03-04 | 2019-05-29 | 77376 |
| TARO-IRBESARTAN | 300MG | TABLET | Resolved | 2019-02-15 | 2021-06-16 | 75896 |
| IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-02-13 | 2019-04-25 | 75548 |
| SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2019-02-12 | 2020-10-27 | 75492 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| TARO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80028 |
| TARO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-03-29 | 2019-03-29 | 80025 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 |